Nova Scotia Becomes Fifth Province to Implement Biosimilar Switching Initiative
Biosimilars Canada welcomes the announcement by the Government of Nova Scotia that it will implement a “switching” or transitioning policy to expand the use of biosimilar medicines under its public drug programs.